A Nova Biomedical Advances implementa fluxos de trabalho integrados voltados ao desenvolvimento de linhagens celulares: Os produtos da NanoCellect agora fazem parte do portfólio da Nova Biomedical

Positive

AI Analysis

Summary

Nova Biomedical acquired certain assets from NanoCellect, a microfluidic cell screening technology company, to expand its cell line development capabilities.

Importance:5/10

Sentiment:

0.50

acquisitioncell line developmentmicrofluidic technologycell screening

Read the original article

Published by PR Newswire Biotech on July 24, 2026 6:07 PM

Read Original